Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84421943 | 8442194 | 3 | F | 20160705 | 20120306 | 20160711 | EXP | BR-AMGEN-BRASP2012012511 | AMGEN | 68.00 | YR | E | F | Y | 69.00000 | KG | 20160711 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84421943 | 8442194 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | 103795 | 50 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | /wk | ||||||
| 84421943 | 8442194 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | 103795 | 50 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | /wk | ||||||
| 84421943 | 8442194 | 3 | C | REUQUINOL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, 1X/DAY | 0 | 400 | MG | QD | ||||||||
| 84421943 | 8442194 | 4 | C | REUQUINOL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, 1X/DAY (ONCE A DAY) | 0 | |||||||||||
| 84421943 | 8442194 | 5 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | ||||||||
| 84421943 | 8442194 | 6 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | 5 MG, 2X/DAY (TWICE A DAY) | 0 | 5 | MG | BID | ||||||||
| 84421943 | 8442194 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 84421943 | 8442194 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 84421943 | 8442194 | 9 | C | RETINOL | RETINOL | 1 | UNK | 0 | |||||||||||
| 84421943 | 8442194 | 10 | C | RETINOL | RETINOL | 1 | UNK | 0 | |||||||||||
| 84421943 | 8442194 | 11 | C | AMARYL | GLIMEPIRIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 84421943 | 8442194 | 1 | Rheumatoid arthritis |
| 84421943 | 8442194 | 7 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 84421943 | 8442194 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 84421943 | 8442194 | Drug ineffective | |
| 84421943 | 8442194 | Lung infection | |
| 84421943 | 8442194 | Pain | |
| 84421943 | 8442194 | Pyrexia | |
| 84421943 | 8442194 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 84421943 | 8442194 | 1 | 20101230 | 0 | ||
| 84421943 | 8442194 | 2 | 20101230 | 201203 | 0 |